Latest From Biotech Now

Q&A on Emmy Award Winning Biotech Education Campaign

Matt Gardner

While the biotechnology industry was born in Northern California over thirty years ago, companies falling under its broad umbrella can now be found in every corner of the world. From humble beginnings, its impact can now be seen in everything from consumer goods to cancer drugs. None-the-less, Northern California remains the center of the industry’s growing orbit. Many of the world’s greatest research institutions and biotech companies were born here and remain headquartered here. To Read More >

Business and Investments  |  Leave a comment  |  Email This Post

Virginia BIO Hosts Free Live Streaming Panel for Start-Ups

webinar

It’s a bit late notice, but if you’re going to be at your desk during lunch today, you should check out the following panel discussion entitled “Entrepreneurship Failures and Successes: The Perspective of Entrepreneurial Faculty.” The Virginia Biotechnology Association (VABIO) is pleased offer an opportunity to view the sold out Greater Richmond Bioscience Luncheon live on the web through our new LiveStream channel. The program will take place Thursday, September 8, from 12:00-1:30 p.m., and program Read More >

Business and Investments  |  Leave a comment  |  Email This Post

“Contagion” Portrays Our Vulnerability to a Global Pandemic

yt

Earlier this month, the movie Contagion opened in theaters. With a star-studded cast including Matt Damon, Kate Winslet, and Gwyneth Paltrow, this action-thriller about the spread of a deadly virus is sure to attract a large audience. While Hollywood has been known to alter or exaggerate the facts to enhance the storyline, it is reported that Steven Soderbergh and his team aimed to realistically portray a pandemic. As Matt Damon stated in an IMDb interview, Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,

Data Protection, Trans Pacific Partnership, and the US-Jordan FTA (Post 2 of 2)

Meeting

This post is a continuation of a previous post: Data Protection, the Trans Pacific Partnership, and the US-Jordan FTA (Post 1 of 2). 4.  Oxfam criticizes pharmaceutical innovators for not making all of their innovative drugs available in Jordan. Ryan responds: a.  Innovator companies introduced few new drugs before IP reform because local companies were using their know-how and clinical data to get marketing approval and brochures describing the drug’s therapeutic function and side effects Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , ,

Data Protection, the Trans Pacific Partnership, and the US-Jordan FTA (Post 1 of 2)

Meeting

The Trans Pacific Partnership (TPP) negotiation does not yet include a section on data protection (typically included in the Pharmaceutical Chapter of Free Trade Agreements).  Organizations against the inclusion of data protection in the TPP cite as evidence an Oxfam International study titled “All Costs, No Benefits: How TRIPS-plus intellectual property rules in the US-Jordan FTA affect access to medicines.” The Oxfam paper concludes that “medicine prices have increased drastically, and TRIPS-plus rules were partly Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , , ,